Terms: = Colorectal cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2
1329 results:
1. Genomic profiling of colorectal cancer in large-scale Chinese patients: amplification and somatic mutations in erbb2.
Liu Y; Bischof E; Chen Z; Zhou J; Zhang B; Zhang D; Gao Y; Quan M
Oncol Res; 2024; 32(9):1429-1438. PubMed ID: 39220126
[TBL] [Abstract] [Full Text] [Related]
2. Kinetic Profiling of
Wu FTH; Topham JT; O'Callaghan CJ; Feilotter H; Kennecke HF; Drusbosky L; Renouf DJ; Jonker DJ; Tu D; Chen EX; Loree JM
JCO Precis Oncol; 2024 Aug; 8():e2400031. PubMed ID: 39178370
[TBL] [Abstract] [Full Text] [Related]
3. Novel erbb2 Variant Potentially Associated with Resistance against Anti-her2 Monoclonal Antibody-Based Therapy in erbb2-Amplified Metastatic colorectal cancer.
Iida N; Imai M; Okamoto W; Kato T; Esaki T; Kato K; Komatsu Y; Yuki S; Masuishi T; Nishina T; Ebi H; Taniguchi H; Nonomura N; Sunakawa Y; Shiozawa M; Yamazaki K; Boku S; Bando H; Shiraishi Y; Kobayashi M; Goto H; Sato A; Fujii S; Yoshino T; Nakamura Y
Clin Cancer Res; 2024 Sep; 30(18):4167-4178. PubMed ID: 39163021
[TBL] [Abstract] [Full Text] [Related]
4. Urachal and Nonurachal Adenocarcinomas of the Urinary Bladder: A Comprehensive Genomic Profiling Study.
Cigliola A; Basnet A; Jacob JM; Mercinelli C; Tateo V; Patanè DA; Bratslavsky G; Cheng L; Grivas P; Kamat AM; Spiess PE; Pavlick DC; Lin DI; Ross JS; Necchi A
JCO Precis Oncol; 2024 Aug; 8():e2400200. PubMed ID: 39151108
[TBL] [Abstract] [Full Text] [Related]
5. Unraveling novel mRNA transcripts of the human DNA N-glycosylase 1 (NTHL1) gene with the implementation of an innovative targeted DNA-seq assay.
Diamantopoulos MA; Adamopoulos PG; Tsiakanikas P; Nisotakis T; Skourou PC; Scorilas A
Gene; 2024 Dec; 930():148856. PubMed ID: 39147115
[TBL] [Abstract] [Full Text] [Related]
6. Trastuzumab deruxtecan in patients with her2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial.
Raghav K; Siena S; Takashima A; Kato T; Van den Eynde M; Pietrantonio F; Komatsu Y; Kawakami H; Peeters M; Andre T; Lonardi S; Yamaguchi K; Tie J; Castro CG; Hsu HC; Strickler JH; Kim TY; Cha Y; Barrios D; Yan Q; Kamio T; Kobayashi K; Boran A; Koga M; Allard JD; Yoshino T
Lancet Oncol; 2024 Sep; 25(9):1147-1162. PubMed ID: 39116902
[TBL] [Abstract] [Full Text] [Related]
7. her2 exon 20 mutant non-small cell lung cancer with complete remission of intracranial metastases with trastuzumab deruxtecan: a case report.
Güren AK; Kocaaslan E; Ağyol Y; Majidova N; Sever N; Erel P; Çelebi A; Arikan R; Işik S; Sari M; Bayoğlu İV; Köstek O
Anticancer Drugs; 2024 Sep; 35(8):769-773. PubMed ID: 39115060
[TBL] [Abstract] [Full Text] [Related]
8. Peptostreptococcus stomatis promotes colonic tumorigenesis and receptor tyrosine kinase inhibitor resistance by activating erbb2-MAPK.
Huang P; Ji F; Cheung AH; Fu K; Zhou Q; Ding X; Chen D; Lin Y; Wang L; Jiao Y; Chu ESH; Kang W; To KF; Yu J; Wong CC
Cell Host Microbe; 2024 Aug; 32(8):1365-1379.e10. PubMed ID: 39059397
[TBL] [Abstract] [Full Text] [Related]
9. Development and biological evaluation of
Zhang J; Lin Y; Gao J; Pan Y; Hou G; Guo C; Gao F
Bioorg Chem; 2024 Oct; 151():107645. PubMed ID: 39059074
[TBL] [Abstract] [Full Text] [Related]
10. Genomic Alterations and Clinical Characterization in Chinese Patients with Metastatic colorectal cancer.
Zhang XH; Zhou JQ; Wei Q; Li J; Xu T; Bai CM; Zhou JF; Wang XC
Discov Med; 2024 Jul; 36(186):1477-1485. PubMed ID: 39054718
[TBL] [Abstract] [Full Text] [Related]
11. Third-line treatment and beyond in metastatic colorectal cancer: What do we have and what can we expect?
Ayala-de Miguel C; Jiménez-Castro J; Sánchez-Vegas A; Díaz-López S; Chaves-Conde M
Crit Rev Oncol Hematol; 2024 Oct; 202():104454. PubMed ID: 39043356
[TBL] [Abstract] [Full Text] [Related]
12. [Clinicopathological analysis of gastric adenocarcinoma with elevated serum alpha-fetoprotein and enteroblastic differentiation].
Zan LK; Shen LL; Zhang X; Gao N; Tian BG; Geng XX; Peng X; Li JW; Bu P; Zhao GH
Zhonghua Zhong Liu Za Zhi; 2024 Jul; 46(7):686-695. PubMed ID: 39034804
[No Abstract] [Full Text] [Related]
13. [Clinical curative effect of enteroscopic stent implantation combined with laparoscopy in patients with colorectal cancer and intestinal obstruction].
Gu JB; Yang H; Bao XB; Ma Z; Gu ZY
Zhonghua Yi Xue Za Zhi; 2024 Jul; 104(28):2637-2641. PubMed ID: 39019821
[TBL] [Abstract] [Full Text] [Related]
14. Current and Emerging Treatment Paradigms in colorectal cancer: Integrating Hallmarks of cancer.
Salva de Torres C; Baraibar I; Saoudi González N; Ros J; Salva F; Rodríguez-Castells M; Alcaraz A; García A; Tabernero J; Élez E
Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000083
[TBL] [Abstract] [Full Text] [Related]
15. Trastuzumab-deruxtecan in solid tumors with her2 alterations: from early phase development to the first agnostic approval of an antibody-drug conjugate.
Edoardo C; Giuseppe C
Expert Opin Investig Drugs; 2024 Aug; 33(8):851-865. PubMed ID: 38967422
[TBL] [Abstract] [Full Text] [Related]
16. Trastuzumab-Deruxtecan: Redefining her2 as a Tumor Agnostic Biomarker.
Zouein J; Karam E; Strickler JH; Kourie HR
Target Oncol; 2024 Sep; 19(5):705-710. PubMed ID: 38963654
[TBL] [Abstract] [Full Text] [Related]
17. her-2 directed therapies across gastrointestinal tract cancers - A new frontier.
Jones L; Cunningham D; Starling N
Cancer Treat Rev; 2024 Sep; 129():102789. PubMed ID: 38959629
[TBL] [Abstract] [Full Text] [Related]
18. [Pharmacological properties and clinical development overview of pertuzumab (genetical recombination), trastuzumab (genetical recombination) and vorhyaluronidase alfa (genetical recombination) (PHESGO
Sakaeda M; Kotani N; Yoneya T; Zheng Y; Habara Y
Nihon Yakurigaku Zasshi; 2024; 159(4):241-253. PubMed ID: 38945908
[TBL] [Abstract] [Full Text] [Related]
19. Progress in clinical diagnosis and treatment of colorectal cancer with rare genetic variants.
Chen S; Gu J; Wu K; Zhao X; Lu Y
Cancer Biol Med; 2024 Jun; 21(6):473-83. PubMed ID: 38940668
[TBL] [Abstract] [Full Text] [Related]
20. Immunohistochemical Expression of Human Epidermal Growth Factor Receptor 2 and Ki67 in Apocrine Gland Anal Sac Adenocarcinoma.
Paiva F; Santos J; Carra G; Sueiro F; Jark P; Nardi A
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928157
[TBL] [Abstract] [Full Text] [Related]
[Next]
